Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Menin inhibitor resistance is associated with the emergence of MEN1

Cancers, Free Full-Text

Acute myeloid leukemia - Wikipedia

Mitochondria in health, disease, and aging

Frontiers Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia

The Menin/KMT2A interaction is a therapeutic target in human MN1

Targeting the undruggable: menin inhibitors ante portas

MD Anderson Research Highlights for February 22, 2023

A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International

Frontiers Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy

High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia